Diagnoz.me won the EHealth 2018!
Home diagnosis kit Jerusalem startup Diagnoz.me has a smartphone system that can detect infections from home and send results to your doctor. Founder and CTO Tamir Epstein described
STEM CELL MEDICINE LICENSES EXOSOME TECHNOLOGY FOR TREATING AUTISM FROM RAMOT, TEL AVIV U
Stem Cell Medicine Ltd. (SCM), a Jerusalem-based biotechnology company developing new therapies for neurological indications, including mesenchymal stem cells and anti-BMP molecules for the treatment
Scade Medical handheld Skin Cancer Diagnotics Scanner is raising funding for Clinical Trials
Scade Medical, (http://scademedical.com) was founded in 2013 by Dr. Ofir Aharon and Mr. Gabi Mizrahi along with first two investors Mr. Shlomi Swissa and Mr.
FDA Approves Teva’s First and Only Digital Inhaler with Built-In Sensors
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved ProAir® Digihaler™ (albuterol sulfate 117
Point of Care Blood Test Co. Sight Diagnostics raises $28m on Start of Marketing of Malaria to Developing Countries
Sight Diagnostics (SightDX), a portfolio company of Anatomy, Clal Biotechnology’s investment fund for medical devices, had raised $28 million. When the round is completed, Anatomy’s
Powermat Wireless Charging Founder Ran Poliakine Launches Innovation Center to Advance Early Stage Wearable Technologies
Ran Poliakine, founder and former CEO of Powermat, has established a new Innovation Center designed to foster and develop new and emerging wearable technologies. The Innovation
RenalSense Conducts Pilot Study on ICU Patient Monitoring at U of Pittsburgh Medical Center
RenalSense® is conducting a pilot study with its Clarity RMS® critical care monitoring system at the University of Pittsburgh Medical Center (UPMC), under the direction of Professor
BrainsWay Selected for USA FDA Innovation Challenge to tackle Opioid Addiction
BrainsWay‘s deep transcranial magnetic stimulation (Deep TMS) system was one of only eight medical devices selected by the U.S. Food and Drug Administration (FDA) from
Pepticom’s AI Discovered 53 Novel Immune-Mmodulators
Pepticom was honored with an image from their article on this December’s Journal of Immunology. The image is taken from Pepticom’s latest article “Computationally Designed Bispecific
